CSF3 and non-Hodgkin lymphoma: In the second study, PEG-G-CSF injection on days zero, two, or four, and G-CSF injection for seven or 10 consecutive days were compared for solid tumor and non-Hodgkin’s lymphoma treated using intermediate and high-risk therapies [1].